BIOPHARM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
BIOPHARM
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€43,547
2024 · -€16,199-€27,348
Equity
€5.4m
2024 · €5.4m-€43,549
Cash
€8,070
2024 · -+€8,070
Balance sheet total
€12.0m
2024 · €11.8m+€207,204
Largest movements
Assets
- Receivables within one year +€485,533
up €485,533 (+10.9%), from €4.4m to €4.9m
of which Trade receivables: +€352,428
- Tangible fixed assets -€282,857
down €282,857 (-4.7%), from €6.0m to €5.7m
of which Land and buildings: -€252,865
Equity and liabilities
- Trade debts +€192,008
up €192,008 (+15.8%), from €1.2m to €1.4m
- Current portion of long-term debt -€156,627
down €156,627 (-24.8%), from €631,880 to €475,253
- Debts after one year +€134,942
up €134,942 (+4.7%), from €2.9m to €3.0m
Income statement
- Turnover +€1.2m
up €1.2m (+12.6%), from €9.2m to €10.3m
- Purchases and services +€1.0m
up €1.0m (+13.5%), from €7.4m to €8.4m
- Gross operating margin +€151,957
up €151,957 (+8.6%), from €1.8m to €1.9m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€16,199
Gross operating margin
+€151,957
Staff costs
-€78,442
Depreciation
-€18,402
Other operating charges
-€21,560
Financial charges
-€60,901
Result 2025
-€43,547
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€241,955
Investment
-€212,198
Financing
-€21,687
Cash 2024
€0
From operations (derived)
+€241,955
Net result for the year
-€43,547
Depreciation
+€495,055
Stocks and contracts
+€3,542
Receivables within one year
-€485,533
Provisions
-€38,233
Trade debts
+€192,008
Tax, wage and social debts
+€7,000
Other debts
+€111,663
Investment (derived)
-€212,198
Investment in fixed assets (net)
-€212,198
Financing
-€21,687
Debts after one year
+€134,942
Current portion of long-term debt
-€156,627
Contributions, distributions and other
-€2
Cash 2025
€8,070
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €11,797,650 | €12,004,854 | +€207,204 | +1.8% |
| Fixed assets | 21/28 | €6,007,413 | €5,724,556 | -€282,857 | -4.7% |
| Tangible fixed assets | 22/27 | €6,007,413 | €5,724,556 | -€282,857 | -4.7% |
| Land and buildings | 22 | €5,688,894 | €5,436,029 | -€252,865 | -4.4% |
| Plant, machinery and equipment | 23 | €238,382 | €176,555 | -€61,827 | -25.9% |
| Furniture and vehicles | 24 | €73,162 | €106,990 | +€33,828 | +46.2% |
| Other tangible fixed assets | 26 | €6,975 | €4,982 | -€1,993 | -28.6% |
| Current assets | 29/58 | €5,790,237 | €6,280,298 | +€490,061 | +8.5% |
| Stocks and contracts in progress | 3 | €1,342,892 | €1,339,350 | -€3,542 | -0.3% |
| Stocks | 30/36 | €1,342,892 | €1,339,350 | -€3,542 | -0.3% |
| Amounts receivable within one year | 40/41 | €4,447,345 | €4,932,878 | +€485,533 | +10.9% |
| Trade receivables | 40 | €621,902 | €974,330 | +€352,428 | +56.7% |
| Other amounts receivable | 41 | €3,825,443 | €3,958,548 | +€133,105 | +3.5% |
| Cash at bank and in hand | 54/58 | - | €8,070 | +€8,070 | |
| Total equity and liabilities | 10/49 | €11,797,650 | €12,004,854 | +€207,204 | +1.8% |
| Equity | 10/15 | €5,413,383 | €5,369,834 | -€43,549 | -0.8% |
| Contributions | 10/11 | €3,453,330 | €3,453,330 | = | 0.0% |
| Capital | 10 | €3,453,330 | €3,453,330 | = | 0.0% |
| Issued capital | 100 | €3,453,330 | €3,453,330 | = | 0.0% |
| Reserves | 13 | €1,960,053 | €1,916,504 | -€43,549 | -2.2% |
| Non-distributable reserves | 130/1 | €28,569 | €30,942 | +€2,373 | +8.3% |
| Legal reserve | 130 | €28,569 | €30,942 | +€2,373 | +8.3% |
| Tax-exempt reserves | 132 | €1,417,732 | €1,326,713 | -€91,019 | -6.4% |
| Distributable reserves | 133 | €513,752 | €558,849 | +€45,097 | +8.8% |
| Provisions and deferred taxes | 16 | €595,520 | €557,287 | -€38,233 | -6.4% |
| Deferred taxes | 168 | €595,520 | €557,287 | -€38,233 | -6.4% |
| Amounts payable | 17/49 | €5,788,747 | €6,077,733 | +€288,986 | +5.0% |
| Amounts payable after more than one year | 17 | €2,850,875 | €2,985,817 | +€134,942 | +4.7% |
| Financial debts | 170/4 | €2,850,875 | €2,985,817 | +€134,942 | +4.7% |
| Amounts payable within one year | 42/48 | €2,937,872 | €3,091,916 | +€154,044 | +5.2% |
| Current portion of amounts payable after more than one year | 42 | €631,880 | €475,253 | -€156,627 | -24.8% |
| Financial debts | 43 | €22,159 | €22,159 | = | 0.0% |
| Credit institutions | 430/8 | €22,159 | €22,159 | = | 0.0% |
| Trade debts | 44 | €1,215,371 | €1,407,379 | +€192,008 | +15.8% |
| Suppliers | 440/4 | €1,215,371 | €1,407,379 | +€192,008 | +15.8% |
| Taxes, remuneration and social security | 45 | €103,730 | €110,730 | +€7,000 | +6.7% |
| Taxes | 450/3 | €70,043 | €81,586 | +€11,543 | +16.5% |
| Remuneration and social security | 454/9 | €33,687 | €29,144 | -€4,543 | -13.5% |
| Other amounts payable | 47/48 | €964,732 | €1,076,395 | +€111,663 | +11.6% |
| Turnover | 70 | €9,173,357 | €10,327,378 | +€1.2m | +12.6% |
| Goods, raw materials, services and sundry goods | 60/61 | €7,412,314 | €8,414,378 | +€1.0m | +13.5% |
| Remuneration, social security and pensions | 62 | €1,104,478 | €1,182,920 | +€78,442 | +7.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €476,653 | €495,055 | +€18,402 | +3.9% |
| Other operating charges | 640/8 | €25,313 | €46,873 | +€21,560 | +85.2% |
| Gross operating margin | 9900 | €1,761,043 | €1,913,000 | +€151,957 | +8.6% |
| Operating profit (loss) | 9901 | €154,599 | €188,152 | +€33,553 | +21.7% |
| Financial charges | 65/66B | €209,030 | €269,931 | +€60,901 | +29.1% |
| Recurring financial charges | 65 | €209,030 | €269,931 | +€60,901 | +29.1% |
| Profit (loss) for the period before taxes | 9903 | -€54,431 | -€81,779 | -€27,348 | -50.2% |
| Transfer from deferred taxes | 780 | €38,232 | €38,232 | = | 0.0% |
| Profit (loss) for the period | 9904 | -€16,199 | -€43,547 | -€27,348 | -169% |
| Transfer from tax-exempt reserves | 789 | €91,018 | €91,018 | = | 0.0% |
| Profit (loss) for the period to be appropriated | 9905 | €74,819 | €47,471 | -€27,348 | -36.6% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.